Flu (Influenza) Vaccine
The global Flu (Influenza) Vaccine market is segmented by company, region (country), by Type, and ... Read More
Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Report 2023
1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Overview
1.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Scope
1.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Segment by Type
1.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2016 & 2021 & 2027)
1.2.2 Live Vaccine
1.2.3 Inactivated Vaccine
1.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Segment by Application
1.3.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Government Tender
1.3.3 Marketing
1.4 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Estimates and Forecasts (2016-2027)
1.4.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price Trends (2016-2027)
2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Estimates and Forecasts by Region
2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Region (2016-2021)
2.2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Region (2016-2021)
2.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Estimates and Projections (2016-2027)
2.4.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Estimates and Projections (2016-2027)
2.4.3 China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Estimates and Projections (2016-2027)
2.4.4 Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Estimates and Projections (2016-2027)
2.4.6 India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Estimates and Projections (2016-2027)
3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Competition Landscape by Players
3.1 Global Top Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Players by Sales (2016-2021)
3.2 Global Top Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Players by Revenue (2016-2021)
3.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) as of 2020)
3.4 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Average Price by Company (2016-2021)
3.5 Manufacturers Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Type
4.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Historic Market Review by Type (2016-2021)
4.1.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2016-2021)
4.1.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Type (2016-2021)
4.1.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Type (2016-2021)
4.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Forecast by Type (2022-2027)
4.2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Forecast by Type (2022-2027)
4.2.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price Forecast by Type (2022-2027)
5 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Application
5.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Historic Market Review by Application (2016-2021)
5.1.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2016-2021)
5.1.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Application (2016-2021)
5.1.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Application (2016-2021)
5.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Forecast by Application (2022-2027)
5.2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Forecast by Application (2022-2027)
5.2.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price Forecast by Application (2022-2027)
6 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures
6.1 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Company
6.1.1 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Company (2016-2021)
6.1.2 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Company (2016-2021)
6.2 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type
6.2.1 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type (2016-2021)
6.2.2 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type (2022-2027)
6.3 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Application
6.3.1 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Application (2016-2021)
6.3.2 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Application (2022-2027)
7 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures
7.1 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Company
7.1.1 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Company (2016-2021)
7.1.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Company (2016-2021)
7.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type
7.2.1 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type (2016-2021)
7.2.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type (2022-2027)
7.3 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Application
7.3.1 Europe 143 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 143 Sales Breakdown by Application (2022-2027)
8 China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures
8.1 China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Company
8.1.1 China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Company (2016-2021)
8.1.2 China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Company (2016-2021)
8.2 China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type
8.2.1 China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type (2016-2021)
8.2.2 China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type (2022-2027)
8.3 China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Application
8.3.1 China 312 Sales Breakdown by Application (2016-2021)
8.3.2 China 312 Sales Breakdown by Application (2022-2027)
9 Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures
9.1 Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Company
9.1.1 Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Company (2016-2021)
9.1.2 Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Company (2016-2021)
9.2 Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type
9.2.1 Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type (2016-2021)
9.2.2 Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type (2022-2027)
9.3 Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures
10.1 Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Company
10.1.1 Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Company (2016-2021)
10.1.2 Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Company (2016-2021)
10.2 Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type
10.2.1 Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures
11.1 India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Company
11.1.1 India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Company (2016-2021)
11.1.2 India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Company (2016-2021)
11.2 India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type
11.2.1 India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type (2016-2021)
11.2.2 India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type (2022-2027)
11.3 India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Application
11.3.1 India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Application (2016-2021)
11.3.2 India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Business
12.1 CNADC
12.1.1 CNADC Corporation Information
12.1.2 CNADC Business Overview
12.1.3 CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
12.1.5 CNADC Recent Development
12.2 Boehringer-Ingelheim
12.2.1 Boehringer-Ingelheim Corporation Information
12.2.2 Boehringer-Ingelheim Business Overview
12.2.3 Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
12.2.5 Boehringer-Ingelheim Recent Development
12.3 MSD Animal Health
12.3.1 MSD Animal Health Corporation Information
12.3.2 MSD Animal Health Business Overview
12.3.3 MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
12.3.5 MSD Animal Health Recent Development
12.4 Sinopharm
12.4.1 Sinopharm Corporation Information
12.4.2 Sinopharm Business Overview
12.4.3 Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
12.4.5 Sinopharm Recent Development
12.5 Ceva
12.5.1 Ceva Corporation Information
12.5.2 Ceva Business Overview
12.5.3 Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
12.5.5 Ceva Recent Development
12.6 Chengdu Tianbang Biological Products Co., Ltd.
12.6.1 Chengdu Tianbang Biological Products Co., Ltd. Corporation Information
12.6.2 Chengdu Tianbang Biological Products Co., Ltd. Business Overview
12.6.3 Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
12.6.5 Chengdu Tianbang Biological Products Co., Ltd. Recent Development
12.7 Tianjin Ruipu Biological Technology Co., Ltd.
12.7.1 Tianjin Ruipu Biological Technology Co., Ltd. Corporation Information
12.7.2 Tianjin Ruipu Biological Technology Co., Ltd. Business Overview
12.7.3 Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
12.7.5 Tianjin Ruipu Biological Technology Co., Ltd. Recent Development
12.8 Qilu Animal Health
12.8.1 Qilu Animal Health Corporation Information
12.8.2 Qilu Animal Health Business Overview
12.8.3 Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
12.8.5 Qilu Animal Health Recent Development
12.9 Guangdong Wens Dahuanong Biotechnology Co., Ltd.
12.9.1 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Corporation Information
12.9.2 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Business Overview
12.9.3 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
12.9.5 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Recent Development
12.10 CAVAC
12.10.1 CAVAC Corporation Information
12.10.2 CAVAC Business Overview
12.10.3 CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
12.10.4 CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
12.10.5 CAVAC Recent Development
12.11 Komipharm
12.11.1 Komipharm Corporation Information
12.11.2 Komipharm Business Overview
12.11.3 Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
12.11.5 Komipharm Recent Development
12.12 Agrovet
12.12.1 Agrovet Corporation Information
12.12.2 Agrovet Business Overview
12.12.3 Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
12.12.5 Agrovet Recent Development
12.13 Bioveta
12.13.1 Bioveta Corporation Information
12.13.2 Bioveta Business Overview
12.13.3 Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
12.13.5 Bioveta Recent Development
12.14 Jinyu Bio-Technology
12.14.1 Jinyu Bio-Technology Corporation Information
12.14.2 Jinyu Bio-Technology Business Overview
12.14.3 Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
12.14.5 Jinyu Bio-Technology Recent Development
12.15 Phibro Animal Health
12.15.1 Phibro Animal Health Corporation Information
12.15.2 Phibro Animal Health Business Overview
12.15.3 Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
12.15.5 Phibro Animal Health Recent Development
12.16 Tiankang
12.16.1 Tiankang Corporation Information
12.16.2 Tiankang Business Overview
12.16.3 Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
12.16.5 Tiankang Recent Development
12.17 Zoetis
12.17.1 Zoetis Corporation Information
12.17.2 Zoetis Business Overview
12.17.3 Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
12.17.5 Zoetis Recent Development
12.18 Guangdong Yongshun Biological Pharmaceutical Co Ltd
12.18.1 Guangdong Yongshun Biological Pharmaceutical Co Ltd Corporation Information
12.18.2 Guangdong Yongshun Biological Pharmaceutical Co Ltd Business Overview
12.18.3 Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
12.18.5 Guangdong Yongshun Biological Pharmaceutical Co Ltd Recent Development
12.19 Plec Bioengineering Co., Ltd.
12.19.1 Plec Bioengineering Co., Ltd. Corporation Information
12.19.2 Plec Bioengineering Co., Ltd. Business Overview
12.19.3 Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
12.19.5 Plec Bioengineering Co., Ltd. Recent Development
13 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Cost Analysis
13.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)
13.4 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Distributors List
14.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Customers
15 Market Dynamics
15.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Trends
15.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Drivers
15.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Challenges
15.4 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) by Region (2016-2021)
Table 5. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Region (2016-2021)
Table 6. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Share by Region (2016-2021)
Table 8. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Share Forecast by Region (2022-2027)
Table 12. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Share by Company (2016-2021)
Table 14. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Share by Company (2016-2021)
Table 16. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) as of 2020)
Table 17. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Average Price (US$/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Sites and Area Served
Table 19. Manufacturers Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) by Type (2016-2021)
Table 22. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Share by Type (2016-2021)
Table 23. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price (US$/Unit) by Type (2016-2021)
Table 25. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Share by Type (2022-2027)
Table 26. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Share by Type (2022-2027)
Table 28. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price (US$/Unit) by Type (2022-2027)
Table 29. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) by Application (2016-2021)
Table 30. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Share by Application (2016-2021)
Table 31. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price (US$/Unit) by Application (2016-2021)
Table 33. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) by Application (2022-2027)
Table 34. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Share by Application (2022-2027)
Table 35. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Share by Application (2022-2027)
Table 37. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price (US$/Unit) by Application (2022-2027)
Table 38. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) by Company (2016-2021)
Table 39. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Company (2016-2021)
Table 40. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Company (2016-2021)
Table 42. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2016-2021) & (K Units)
Table 43. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2016-2021)
Table 44. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2022-2027) & (K Units)
Table 45. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2022-2027)
Table 46. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2016-2021) & (K Units)
Table 47. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2016-2021)
Table 48. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2022-2027) & (K Units)
Table 49. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2022-2027)
Table 50. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) by Company (2016-2021)
Table 51. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Company (2016-2021)
Table 52. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Company (2016-2021)
Table 54. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2016-2021) & (K Units)
Table 55. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2016-2021)
Table 56. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2022-2027) & (K Units)
Table 57. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2022-2027)
Table 58. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2016-2021) & (K Units)
Table 59. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2016-2021)
Table 60. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2022-2027) & (K Units)
Table 61. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2022-2027)
Table 62. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) by Company (2016-2021)
Table 63. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Company (2016-2021)
Table 64. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Company (2016-2021)
Table 66. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2016-2021) & (K Units)
Table 67. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2016-2021)
Table 68. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2022-2027) & (K Units)
Table 69. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2022-2027)
Table 70. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2016-2021) & (K Units)
Table 71. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2016-2021)
Table 72. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2022-2027) & (K Units)
Table 73. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2022-2027)
Table 74. Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) by Company (2016-2021)
Table 75. Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Company (2016-2021)
Table 76. Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Company (2016-2021)
Table 78. Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2016-2021) & (K Units)
Table 79. Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2016-2021)
Table 80. Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2022-2027) & (K Units)
Table 81. Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2022-2027)
Table 82. Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2016-2021) & (K Units)
Table 83. Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2016-2021)
Table 84. Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2022-2027) & (K Units)
Table 85. Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2022-2027)
Table 98. India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) by Company (2016-2021)
Table 99. India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Company (2016-2021)
Table 100. India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Company (2016-2021)
Table 102. India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2016-2021) & (K Units)
Table 103. India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2016-2021)
Table 104. India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2022-2027) & (K Units)
Table 105. India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2022-2027)
Table 106. India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2016-2021) & (K Units)
Table 107. India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2016-2021)
Table 108. India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2022-2027) & (K Units)
Table 109. India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2022-2027)
Table 110. CNADC Corporation Information
Table 111. CNADC Description and Business Overview
Table 112. CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 114. CNADC Recent Development
Table 115. Boehringer-Ingelheim Corporation Information
Table 116. Boehringer-Ingelheim Description and Business Overview
Table 117. Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 119. Boehringer-Ingelheim Recent Development
Table 120. MSD Animal Health Corporation Information
Table 121. MSD Animal Health Description and Business Overview
Table 122. MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 124. MSD Animal Health Recent Development
Table 125. Sinopharm Corporation Information
Table 126. Sinopharm Description and Business Overview
Table 127. Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 129. Sinopharm Recent Development
Table 130. Ceva Corporation Information
Table 131. Ceva Description and Business Overview
Table 132. Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 134. Ceva Recent Development
Table 135. Chengdu Tianbang Biological Products Co., Ltd. Corporation Information
Table 136. Chengdu Tianbang Biological Products Co., Ltd. Description and Business Overview
Table 137. Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 138. Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 139. Chengdu Tianbang Biological Products Co., Ltd. Recent Development
Table 140. Tianjin Ruipu Biological Technology Co., Ltd. Corporation Information
Table 141. Tianjin Ruipu Biological Technology Co., Ltd. Description and Business Overview
Table 142. Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 143. Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 144. Tianjin Ruipu Biological Technology Co., Ltd. Recent Development
Table 145. Qilu Animal Health Corporation Information
Table 146. Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 147. Qilu Animal Health Description and Business Overview
Table 148. Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 149. Qilu Animal Health Recent Development
Table 150. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Corporation Information
Table 151. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 152. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Description and Business Overview
Table 153. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 154. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Recent Development
Table 155. CAVAC Corporation Information
Table 156. CAVAC Description and Business Overview
Table 157. CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 158. CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 159. CAVAC Recent Development
Table 160. Komipharm Corporation Information
Table 161. Komipharm Description and Business Overview
Table 162. Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 163. Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 164. Komipharm Recent Development
Table 165. Agrovet Corporation Information
Table 166. Agrovet Description and Business Overview
Table 167. Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 168. Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 169. Agrovet Recent Development
Table 170. Bioveta Corporation Information
Table 171. Bioveta Description and Business Overview
Table 172. Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 173. Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 174. Bioveta Recent Development
Table 175. Jinyu Bio-Technology Corporation Information
Table 176. Jinyu Bio-Technology Description and Business Overview
Table 177. Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 178. Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 179. Jinyu Bio-Technology Recent Development
Table 180. Phibro Animal Health Corporation Information
Table 181. Phibro Animal Health Description and Business Overview
Table 182. Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 183. Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 184. Phibro Animal Health Recent Development
Table 185. Tiankang Corporation Information
Table 186. Tiankang Description and Business Overview
Table 187. Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 188. Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 189. Tiankang Recent Development
Table 190. Zoetis Corporation Information
Table 191. Zoetis Description and Business Overview
Table 192. Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 193. Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 194. Zoetis Recent Development
Table 195. Guangdong Yongshun Biological Pharmaceutical Co Ltd Corporation Information
Table 196. Guangdong Yongshun Biological Pharmaceutical Co Ltd Description and Business Overview
Table 197. Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 198. Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 199. Guangdong Yongshun Biological Pharmaceutical Co Ltd Recent Development
Table 200. Plec Bioengineering Co., Ltd. Corporation Information
Table 201. Plec Bioengineering Co., Ltd. Description and Business Overview
Table 202. Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 203. Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 204. Plec Bioengineering Co., Ltd. Recent Development
Table 205. Production Base and Market Concentration Rate of Raw Material
Table 206. Key Suppliers of Raw Materials
Table 207. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Distributors List
Table 208. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Customers List
Table 209. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Trends
Table 210. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Drivers
Table 211. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Challenges
Table 212. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Restraints
Table 213. Research Programs/Design for This Report
Table 214. Key Data Information from Secondary Sources
Table 215. Key Data Information from Primary Sources
List of Figures
Figure 1. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Picture
Figure 2. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application in 2021 & 2027
Figure 6. Government Tender Examples
Figure 7. Marketing Examples
Figure 8. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) Growth Rate (2016-2027)
Figure 11. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price Trends Growth Rate (2016-2027) (US$/Unit)
Figure 12. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) Growth Rate (2016-2027)
Figure 16. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Players Market Share by Revenue in Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS): 2016 & 2020
Figure 27. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Share by Type (2016-2021)
Figure 29. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Share by Application (2016-2021)
Figure 31. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type in 2020
Figure 33. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application in 2020
Figure 34. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type in 2020
Figure 35. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application in 2020
Figure 36. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type in 2020
Figure 37. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application in 2020
Figure 38. Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type in 2020
Figure 39. Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application in 2020
Figure 40. Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type in 2020
Figure 41. Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application in 2020
Figure 42. India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type in 2020
Figure 43. India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)
Figure 46. Manufacturing Process Analysis of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)
Figure 47. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
CNADC Boehringer-Ingelheim MSD Animal Health Sinopharm Ceva Chengdu Tianbang Biological Products Co., Ltd. Tianjin Ruipu Biological Technology Co., Ltd. Qilu Animal Health Guangdong Wens Dahuanong Biotechnology Co., Ltd. CAVAC Komipharm Agrovet Bioveta Jinyu Bio-Technology Phibro Animal Health Tiankang Zoetis Guangdong Yongshun Biological Pharmaceutical Co Ltd Plec Bioengineering Co., Ltd.